Japan approves Covaxin as a booster dose for travellers

BL Hyderabad Bureau | | Updated on: Aug 05, 2022
Covaxin receives another global recognition

Covaxin receives another global recognition

A notification issued by the Japanese authorities includes Covaxin in the list of vaccines which are recognised for the booster

Covaxin, the Covid-19 vaccine of Bharat Biotech International Ltd, has been approved by Japan as a booster dose for travellers.  

“We are proud to announce, Japan has approved Covaxin booster dose for travellers. Another global recognition of the effectiveness of our universal Covid vaccine,” Hyderabad-based Bharat Biotech said in an update on Friday. 

Recognised for booster

A notification issued by the Japanese authorities includes Covaxin in the list of vaccines which are recognised for the booster (third dose). The certificate must clearly indicate that you have received a third dose, with it being one of the following vaccines: Comirnaty — Pfizer, Spikevax — Moderna, Nuvaxovid — Novavax, Vaxzevria —AstraZeneca, Jcovden — Janssen, Covaxin — Bharat Biotech (effective from July 31, 2022), it said.

 In applying measures based on New Border Measures of Japan, Comirnaty manufactured by Fosun Pharma / BioNTech and Covishield / Covovax manufactured by the Serum Institute of India are treated as identical to Comirnaty, Pfizer and Vaxzevria, AstraZeneca, and Nuvaxovid, INovavax respectively,” the notification issued by the Quarantine Station, Ministry of Health, Labour and Welfare, Japanese Government said. 

 A valid vaccination certificate must be presented at the quarantine station at the time of entry, as per the notification.

Published on August 05, 2022
COMMENTS
  1. Comments will be moderated by The Hindu BusinessLine editorial team.
  2. Comments that are abusive, personal, incendiary or irrelevant cannot be published.
  3. Please write complete sentences. Do not type comments in all capital letters, or in all lower case letters, or using abbreviated text. (example: u cannot substitute for you, d is not 'the', n is not 'and').
  4. We may remove hyperlinks within comments.
  5. Please use a genuine email ID and provide your name, to avoid rejection.

You May Also Like

Recommended for you